ArticleBrain and behavior2026
Association of Admission Glucose-to-Lymphocyte Ratio With 90-Day Functional Outcome in Patients With Acute Ischemic Stroke Treated With Intravenous Thrombolysis.
Article in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThe glucose-to-lymphocyte ratio (GLR), a composite biomarker reflecting metabolic and immune-inflammatory status, has shown prognostic value in several clinical settings. However, its relevance in patients with acute ischemic stroke (AIS) undergoing intravenous thrombolysis (IVT) remains unclear. We investigated the association between admission GLR and poor functional outcome at 90 days in this population.
methodsIn this retrospective single-center study, consecutive patients with AIS treated with IVT between May 2016 and December 2025 were included. The primary outcome was poor functional outcome at 90 days, defined as a modified Rankin Scale score of 3-6. GLR was analyzed as both a continuous and a categorical variable. Multivariable logistic regression, inverse probability weighting, restricted cubic spline analysis, subgroup analyses, and sensitivity analyses were performed after multiple imputation for missing data.
resultsAmong 785 patients, 29.64% had poor functional outcome at 90 days. The optimal GLR cutoff was 4.137, with a pooled AUC of 0.623 (95% CI 0.578-0.665). In the fully adjusted model, GLR was independently associated with poor outcome both as a continuous variable (OR = 1.071, 95% CI 1.004-1.144, p = 0.038) and as a categorical variable (OR = 1.639, 95% CI 1.057-2.543, p = 0.027). The findings remained robust in an alternative lipid-adjusted model and IPW analyses. RCS analysis suggested an overall linear association, whereas sensitivity analyses using an alternative mRS dichotomization were not statistically significant.
conclusionsElevated admission GLR was independently associated with an increased risk of poor functional outcome at 90 days in patients with AIS undergoing IVT. GLR may provide useful supplementary prognostic information for early risk stratification, although its standalone discriminatory performance was modest.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.